Clinical and Life Sciences · 28 September 2026 to 28 September 2026 · 1 headlines · MedCity News
Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch
Merck has agreed to pay $400 million to acquire a cancer drug prospect from China-based SciBrunch.
As it ran
28 September 2026
More from US healthcare
- One Shot or Two? What to Know About HPV Vaccination Recommendations 28 September 2026
- Memorial Hermann CEO retirement 28 September 2026
- 15M Americans live in a county with no general surgeons: study 28 September 2026
- Few Lab Tests Actually Need 8 Hours of Fasting, Study Suggests 28 September 2026
- First New Drug Approved for Idiopathic Nephrotic Syndrome in 70 Years 28 September 2026
- I discovered a new structure in the heart — just by looking closely 28 September 2026
- Parkinson's Disease Gets New Treatment Approved 28 September 2026
- Risk from toxic metals can persist months after wildfires, Maui study finds 28 September 2026